Therapy of the hyperlipidemias

Area of Science:

• Cardiology
• Metabolic Disorders

Background:

• Hyperlipidemia, characterized by elevated plasma cholesterol and triglycerides, is a significant risk factor for atherosclerosis.
• Establishing universal upper limits for normal lipid levels remains challenging, yet increased concentrations correlate with heightened cardiovascular risk.

Purpose of the Study:

• To outline the diagnostic criteria and therapeutic strategies for managing hyperlipidemia.
• To emphasize the importance of individualized risk-benefit assessments in treatment decisions.

Main Methods:

• Defining upper limits for normal plasma cholesterol (220 mg/100 ml) and triglycerides (140 mg/100 ml).
• Prioritizing dietary modifications as the primary treatment approach for hyperlipidemia.
• Considering pharmacologic intervention when diet alone is insufficient to achieve lipid goals.

Main Results:

• Atherosclerosis risk escalates with increasing plasma cholesterol and triglyceride levels.
• Dietary changes are the initial therapeutic step in managing hyperlipidemia.
• Drug therapy is a subsequent option, contingent upon patient-specific risk-benefit analysis.

Conclusions:

• Effective hyperlipidemia management aims to mitigate or halt atherosclerosis progression.
• Treatment decisions, particularly regarding medication, necessitate ongoing evaluation due to evolving medical knowledge.
• Regularly updating treatment plans ensures optimal patient outcomes in managing lipid disorders.